miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression

Wenjing Mu(Hefei University of Technology), Lijian Hui(Chinese Academy of Sciences), Chaobo Hu(Shanghai Institutes for Biological Sciences), Xianghuo He(Shanghai Cancer Institute), Zhixin Qiu(University of California San Diego), Zengqiang Qu(Second Military Medical University), Chao Li(First Affiliated Hospital of Xi'an Jiaotong University), Haibin Zhang(Second Military Medical University), Xiaolei Shi(Nanjing Drum Tower Hospital), Yixue Li(King University), Haozhen Ren(Nanjing Drum Tower Hospital), Jin Cen(Shanghai Institutes for Biological Sciences)
Cell Research
February 20, 2015
Cited by 99


Related Papers